News from CMRB
Ten years ago, Dr. Yamanaka and Dr. Takahashi published a manuscript where they explained how he obtained stem cells from mouse skin cells. This kind of stem cells were called induced pluripotent stem cells (iPSCs). For that, Yamanaka was awarded years after with the Novel Prize in Medicine. In the ten years that have passed since, iPSC technology has provided fundamental insights into our understanding of cell fate, mammalian development, and human disease.
In 2006, when Dr. Yamanaka announced the discovery of mouse iPSCs in a symposium in Granada, most of the researchers there could not believe it. However, researchers at the CMR[B] were sure that if that could be true in humans too, would be a great achievement that would change the whole fate of the field of stem cell research. Thus, the CMR[B] began to focus on the generation of human iPSC. About 2 years after, the CMR[B] was the first research center in Europe to create them. Concerning regenerative medicine, the director of the CMR[B] Ángel Raya, is convinced that in a few years, the translation to clinics will be very close. The CMR[B] team, in collaboration with other national and international institutions, is working hard every day to bring this research to patients.